176219-90-2

Upstream product

• 38781-50-9 2-(17β-acetoxy-2-hydroxy-estra-1,3,5(10)-trien-3-yloxy)-5-nitro-benzophenone 
• 100-44-7 benzyl chloride 

Downstream Products

• 176219-98-0 Acetic acid (8R,9S,13R,14S,15S,16S,17S)-16,17-diacetoxy-2,3-bis-benzyloxy-14-hydroxy-13-methyl-7,8,9,11,12,13,14,15,16,17-decahydro-6H-cyclopenta[a]phenanthren-15-yl ester 
• 176219-97-9 Acetic acid (8R,9S,13R,14S,15R,16R,17S)-16,17-diacetoxy-2,3-bis-benzyloxy-14-hydroxy-13-methyl-7,8,9,11,12,13,14,15,16,17-decahydro-6H-cyclopenta[a]phenanthren-15-yl ester 
• 176220-00-1 (8R,9S,13R,14S,15S,16S,17S)-2,3-Bis-benzyloxy-13-methyl-6,7,8,9,11,12,13,15,16,17-decahydro-cyclopenta[a]phenanthrene-14,15,16,17-tetraol 
• 176219-99-1 (8R,9S,13R,14S,15R,16R,17S)-2,3-Bis-benzyloxy-13-methyl-6,7,8,9,11,12,13,15,16,17-decahydro-cyclopenta[a]phenanthrene-14,15,16,17-tetraol 
• 176219-94-6 (8R,9S,13S,14S)-2,3-Bis-benzyloxy-14-hydroxy-13-methyl-6,7,8,9,11,12,13,14-octahydro-cyclopenta[a]phenanthren-17-one 
• 176219-95-7 (8R,9S,13R,14S,17R)-2,3-Bis-benzyloxy-13-methyl-6,7,8,9,11,12,13,17-octahydro-cyclopenta[a]phenanthrene-14,17-diol 
• 176219-92-4 (8R,9S,13S,14S)-2,3-Bis-benzyloxy-13-methyl-6,7,8,9,11,12,13,14-octahydro-cyclopenta[a]phenanthren-17-one 
• 176219-89-9 (14β,15α,16α,17α)-1,3,5(10)-estratriene-2,3,14,15,16,17-hexaol 
• 176219-89-9 (14β,15β,16β,17α)-1,3,5(10)-estratriene-2,3,14,15,16,17-hexaol 
• 176219-91-3 ((8R,9S,13S,14S)-2,3-Bis-benzyloxy-13-methyl-7,8,9,11,12,13,14,15-octahydro-6H-cyclopenta[a]phenanthren-17-yloxy)-triethyl-silane 
• 176219-93-5 (8R,9S,13S)-2,3-Bis-benzyloxy-13-methyl-6,7,8,9,11,12,13,16-octahydro-cyclopenta[a]phenanthren-17-one 
• 51478-04-7 2,3-dibenzyloxy-1,3,5⁽¹⁰⁾-estratriene-17-one 
• 38781-43-0 (17β)-2,3-dibenzyloxy-1,3,5(10)-estratriene-17-ol 
• 22145-26-2 (17β)-2-benzyloxy-1,3,5(10)-estratriene-3,17-diol 

Relevant academic research and scientific papers

Syntheses of (14β,15β,16β,17α)- and (14β,15α,16α,17α)-1,3,5(10)-Estratriene-2,3,14,15, 16,17-hexaols, Possible Candidates for the Inagami-Tamura Endogenous Digitalis-like Factor, and Their Activity

Structures are proposed for the Inagami-Tamura endogenous digitalis-like factor (EDLF), and two possible candidates, (14β,15β,16β,17α)- and (14β,15α,16α,17α)-2,3,14,15,16,17-hexahydroxy-1,3,5(10)- estratrienes, were synthesized. Both compounds were potent in inducing a contractile response in isolated rat aorta and guinea pig left atrium.